Navis Wealth Advisors LLC bought a new stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) in the 1st quarter, according to its most recent 13F filing with the SEC. The firm bought 3,000 shares of the financial services provider's stock, valued at approximately $334,000.
Other institutional investors also recently made changes to their positions in the company. Whipplewood Advisors LLC acquired a new position in shares of Aflac during the 4th quarter valued at $26,000. Garde Capital Inc. acquired a new position in Aflac during the 1st quarter worth approximately $36,000. BankPlus Trust Department purchased a new position in Aflac in the 4th quarter worth approximately $34,000. Curio Wealth LLC purchased a new position in Aflac in the 4th quarter worth approximately $36,000. Finally, Capital A Wealth Management LLC acquired a new stake in Aflac in the fourth quarter valued at approximately $38,000. 67.44% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities research analysts recently weighed in on AFL shares. Wells Fargo & Company raised their price target on shares of Aflac from $102.00 to $103.00 and gave the company an "equal weight" rating in a report on Tuesday, May 6th. Barclays increased their target price on Aflac from $95.00 to $96.00 and gave the company an "underweight" rating in a research note on Thursday, May 1st. JPMorgan Chase & Co. raised their price objective on shares of Aflac from $94.00 to $96.00 and gave the stock a "neutral" rating in a report on Wednesday, April 2nd. UBS Group upped their target price on shares of Aflac from $109.00 to $114.00 and gave the company a "neutral" rating in a research note on Wednesday, April 2nd. Finally, Keefe, Bruyette & Woods upped their price target on Aflac from $104.00 to $106.00 and gave the company a "market perform" rating in a research report on Wednesday, May 7th. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $104.93.
Get Our Latest Stock Report on Aflac
Aflac Stock Performance
Shares of AFL opened at $104.89 on Tuesday. The company's fifty day moving average price is $104.84 and its 200 day moving average price is $105.22. Aflac Incorporated has a one year low of $88.00 and a one year high of $115.50. The company has a market capitalization of $56.71 billion, a PE ratio of 16.39, a price-to-earnings-growth ratio of 3.20 and a beta of 0.82. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.09 and a quick ratio of 0.09.
Aflac (NYSE:AFL - Get Free Report) last issued its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). Aflac had a net margin of 21.27% and a return on equity of 15.55%. The firm had revenue of $3.40 billion during the quarter, compared to analyst estimates of $4.53 billion. During the same quarter in the previous year, the company posted $1.66 earnings per share. The business's revenue for the quarter was down 37.5% compared to the same quarter last year. As a group, analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current year.
Aflac Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, June 2nd. Investors of record on Wednesday, May 21st were given a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.21%. The ex-dividend date of this dividend was Wednesday, May 21st. Aflac's dividend payout ratio is currently 36.25%.
Insider Buying and Selling
In other news, Director Masatoshi Koide sold 37,000 shares of Aflac stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total value of $3,906,830.00. Following the sale, the director now directly owns 70,992 shares in the company, valued at $7,496,045.28. This trade represents a 34.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of the company's stock in a transaction dated Thursday, May 8th. The stock was sold at an average price of $106.79, for a total value of $106,790.00. Following the sale, the director now owns 26,096 shares in the company, valued at $2,786,791.84. The trade was a 3.69% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 40,750 shares of company stock valued at $4,304,295. 0.80% of the stock is owned by company insiders.
Aflac Company Profile
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Read More
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.